Instem proves in step with groundbreaking market needs as it posts strong 2022 performance | News Direct

Instem proves in step with groundbreaking market needs as it posts strong 2022 performance

Instem PLC
News release by Instem PLC

facebook icon linkedin icon twitter icon pinterest icon email icon London, UK | May 17, 2023 03:00 AM Eastern Daylight Time

 

Phil Reason, CEO of Instem PLC, joined Proactive with details of the company's 2022 financial performance. The company grew revenues by 28% and underlying earnings were up 32%. It also said it expected to benefit in 2023 from ‘industry consolidation’. Recent success include increased recurring revenue and a renewed contract with the US government's National Toxicology Program.

 

Contact Details

 

Proactive UK Ltd

 

Proactive UK Ltd

 

+44 20 7989 0813

 

uk@proactiveinvestors.com

project media

Tags

BiotechnologyToxicologyPharmalife sciencesHealth IT solutions